Terns Pharmaceuticals, Inc. · NASDAQ:TERN
Schonfeld Strategic Advisors LLC's stake in Terns Pharmaceuticals, Inc. fell to 4.93% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Schonfeld Strategic Advisors LLC's stake in Terns Pharmaceuticals, Inc. fell to 4.93%, 4,305,204 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 4.93%
- Shares
- 4,305,204
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Schonfeld Strategic Advisors LLC | 4.93% | 4,305,204 |
Source
Related
- Terns Pharmaceuticals, Inc.
- Schonfeld Strategic Advisors LLC
- Terns Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Schonfeld Strategic Advisors LLC · Feb 14, 2025
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Form 4 · Kuriakose Emil · May 5, 2026
- Form 4 · Gengos Andrew · May 5, 2026